Less Ads, More Data, More Tools Register for FREE

Pin to quick picksImpact Health Regulatory News (IHR)

  • There is currently no data for IHR

Acquisition

26 Mar 2018 07:00

RNS Number : 8382I
Impact Healthcare REIT PLC
26 March 2018
 

26 March 2018

Impact Healthcare REIT plc

(the "Company" and with its subsidiaries, the "Group")

ACQUISITION OF A CARE HOME IN BRISTOL

The Board of Directors of Impact Healthcare REIT plc (ticker: IHR) is pleased to announce that the Group has acquired, in a sale and leaseback transaction, a care home in Bristol for a total consideration of £4.9 million (including costs).

 

The home operates as two units on one site: Fairview Court and Fairview House. It is being sold by its current owners as part of their retirement from the business. On completion the home will be operated by Welford Healthcare Limited ("Welford"), which is owned and managed by Peter Madden, a high quality operator with an established track record of successfully managing and adding value to care homes. The Group will enter into a new full repairing and insuring lease with Welford for an initial term of 25 years, with an option for Welford to extend to 35 years. Welford has committed to a minimum annual expenditure on maintenance.

 

The initial rent of £356,000 receivable under the lease is subject to annual, upward only rent reviews, increasing in line with the Retail Prices Index, with a floor of 2% p.a. and a cap of 4% p.a.

 

Fairview Court was built by the vendors in 2006 with 49 single bedrooms, all are en-suite, providing nursing with dementia care. Fairview House is a 22-bed unit in a period building, providing residential care. Both units are rated "Good" by the Care Quality Commission and are operating at or near full capacity.

 

The Board believes that the principal benefits that make this care home an attractive addition to the Company's portfolio include:

· the level of initial rent agreed with Welford offers us an attractive net initial yield, combined with a high level of rent cover to ensure the rent is sustainable;

· a clear path to increase the rent through a programme of active asset management. Planning permission is in place to extend Fairview House and to link the two units. Once this work is completed, it will be possible to operate the home as one unit, offering 79 bedrooms, all en-suite and refurbished to a high standard; and

· the addition of a dynamic new tenant, with whom we intend to do further business.

The home is one of the target acquisitions identified by the Group at the time of the fundraise completed in November 2017 and is in line with the Group's strict investment criteria and returns profile. The Group has also agreed exclusivity on a number of further acquisitions, and continues to evaluate a strong attractive pipeline of potential investment opportunities.

 

FOR FURTHER INFORMATION, PLEASE CONTACT:

Impact Health Partners LLP

Mahesh Patel

Andrew Cowley

via Newgate Communications

 

 

Winterflood Securities Limited

Joe Winkley

Neil Langford

Tel: 020 3100 0000

 

 

Newgate Communications (PR Adviser)

James Benjamin

Anna Geffert

Patrick Hanrahan

Leena Patel

Tel: 020 7680 6550

Email: impact@newgatecomms.com

 

The Company's LEI is 213800AX3FHPMJL4IJ53.

 

Further information on Impact Healthcare REIT is available at www.impactreit.uk

 

NOTES:

The Group is a real estate investment trust ("REIT") which aims to provide shareholders with an attractive return, principally in the form of quarterly income distributions and with the potential for capital and income growth, through exposure to a diversified portfolio of healthcare real estate opportunities, in particular residential care homes. The Group's investment policy is to acquire, renovate, extend and redevelop high quality healthcare real estate assets in the UK and lease those assets primarily to healthcare operators providing residential healthcare services under full repairing and insuring leases.

The Group is targeting an aggregate dividend of 6.0 pence per share for the first 12 months from Admission which equates to a yield of 6 per cent. per annum on the IPO Issue Price, payable in quarterly instalments(1).

The Group's Ordinary Shares were admitted to trading on the main market of the London Stock Exchange, Specialist Fund Segment, on 7 March 2017.

(1) This is a target only and not a profit forecast and there can be no assurance that it will be met and it should not be taken as an indication of the Group's actual or expected future results.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQPGUPAWUPRGUA
Date   Source Headline
27th Apr 20187:00 amRNSNet Asset Value and Dividend
27th Apr 20187:00 amRNSResult of AGM
20th Apr 20182:03 pmRNSHolding(s) in Company
26th Mar 20184:38 pmRNSNotice of AGM
26th Mar 20187:00 amRNSAcquisition
21st Mar 20187:00 amRNSFULL YEAR RESULTS
20th Mar 20182:17 pmRNSHolding(s) in Company
16th Mar 20184:34 pmRNSNotice of Results
14th Mar 20182:54 pmRNSHolding(s) in Company
13th Mar 20183:40 pmRNSHolding(s) in Company
2nd Mar 201811:00 amRNSHolding(s) in Company
7th Feb 20184:13 pmRNSNET ASSET VALUE AND DIVIDEND
1st Feb 20187:00 amRNSDividend Declaration
11th Jan 20187:00 amRNSAcquisition
20th Dec 201710:34 amRNSHolding(s) in Company
16th Nov 201711:56 amRNSHolding(s) in Company
10th Nov 20174:44 pmRNSHolding(s) in Company
8th Nov 20177:00 amRNSSuccessful fund raising of £32.6 million
6th Nov 20172:58 pmRNSResult of General Meeting
1st Nov 20177:00 amRNSDividend Declaration
16th Oct 20177:00 amRNSNet Asset Value and Proposed Placing
22nd Sep 20177:00 amRNSINTERIM RESULTS FOR THE PERIOD TO 30 JUNE 2017
31st Jul 20175:43 pmRNSTrading Update and Dividend Declaration
31st Jul 20177:00 amRNSTrading Update
30th Jun 20177:00 amRNSStatement re Change in accounting reference date
30th Jun 20177:00 amRNSStatement re Appointment of Non-Executive Director
29th Jun 20177:00 amRNSAcquisition of Saffron Court
17th May 20177:00 amRNSNotification of Home State
4th May 20177:00 amRNSAcquisition of Seed Portfolio
10th Mar 20173:13 pmRNSHolding(s) in Company
9th Mar 201712:10 pmRNSDirector/PDMR Shareholding
9th Mar 201712:10 pmRNSDirector/PDMR Shareholding
9th Mar 201712:09 pmRNSDirector/PDMR Shareholding
9th Mar 201712:09 pmRNSDirector/PDMR Shareholding
7th Mar 20178:01 amRNSFirst day of dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.